The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Number of tumor-infiltrating lymphocytes in breast cancer brain metastases compared to matched breast primaries.
 
Jessie Narloch
No Relationships to Disclose
 
Catherine Luedke
No Relationships to Disclose
 
Gloria Broadwater
No Relationships to Disclose
 
Nolan Priedigkeit
No Relationships to Disclose
 
Allison Hall
No Relationships to Disclose
 
Terry Hyslop
No Relationships to Disclose
 
Sarah LeNoir Sammons
No Relationships to Disclose
 
Shannon Leigh Huggins-Puhalla
No Relationships to Disclose
 
Jose Pablo Leone
No Relationships to Disclose
 
Juanita Ramirez
No Relationships to Disclose
 
John P Kirkpatrick
No Relationships to Disclose
 
Matt G Ewend
Leadership - Falcon Therapeutics
Stock and Other Ownership Interests - Falcon Therapeutics
 
Peter E Fecci
No Relationships to Disclose
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Bayer; bioTheranostics; Celgene; Genentech/Roche; Genomic Health; Lilly; NanoString Technologies; Novartis; Pfizer; Puma Biotechnology
 
Adrian V. Lee
No Relationships to Disclose
 
Carey K. Anders
Consulting or Advisory Role - Angiochem; Genentech/Roche; GERON; Kadmon; Lilly; Merrimack; Nektar; Novartis; Sanofi; to-BBB technologies BV
Research Funding - Angiochem (Inst); Cascadian Therapeutics (Inst); Geron (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Oncothyreon (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tesaro (Inst); to-BBB technologies BV (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com
 
Kimberly L. Blackwell
Consulting or Advisory Role - Advaxis; Amgen; Amgen; Bayer; Celgene; Coherus Biosciences; Eisai; G1 Therapeutics; Genentech; Incyte; Lilly; Macrogenics; Merck; Novartis; Pfizer; Pierian Biosciences; Puma Biotechnology; Roche; Sandoz; Spectrum Pharmaceuticals
Research Funding - Genentech (Inst); Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Advaxis; Amgen; Celgene; Coherus Biosciences; Eisai; Genentech; Lilly; Macrogenics; Merck; Novartis; Pfizer; Pierian Biosciences; Puma Biotechnology; Roche; Sandoz